Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

230 results about "Atrophic mucosa" patented technology

Jump to navigation Jump to search. Atrophic gastritis (also known as Type A or Type B Gastritis more specifically) is a process of chronic inflammation of the stomach mucous membrane (mucosa), leading to loss of gastric glandular cells and their eventual replacement by intestinal and fibrous tissues.

Traditional Chinese medicinal formula for treating gastropathy

The invention discloses a traditional Chinese medicinal formula for treating gastropathy. The formula comprises Radix Codonopsis, Radix Astragali, Radix Pseudostellariae, Mythic Fungus, white peony root, Chinese angelica, Rhizoma Atractylodis Macrocephalae, Chinese yam, haw, malt, medicated leaven, Atractylodes lancea, Panax Notoginseng, radix bupleuri, Rhizoma Cyperi, Rhizoma Corydalis, cuttlefish bone, Radix et Rhizoma Nardostachyos, Immature Bitter Orange, Poria cocos, Villous Amomum Fruit, dried orange peel, Radix Aucklandiae, chicken's gizzard membrane, cortex magnoliae officinalis and licorice according to the monarch, minister, assistant and guide of the traditional Chinese medicinal science. The monarch medicines comprise the Radix Codonopsis, the Radix Pseudostellariae, the Radix Astragali and the Mythic Fungus; the minister medicines comprise the white peony root, the Chinese angelica, the Rhizoma Atractylodis Macrocephalae, the Chinese yam, the haw, the malt, the medicated leaven, the Atractylodes lancea, the Panax Notoginseng, the radix bupleuri, the Rhizoma Cyperi, the Rhizoma Corydalis, the cuttlefish bone and the Radix et Rhizoma Nardostachyos; the assistant medicines comprise the Immature Bitter Orange, the Poria cocos, the Villous Amomum Fruit, the dried orange peel, the Radix Aucklandiae, the chicken's gizzard membrane and the cortex magnoliae officinalis; and the guide medicine is the licorice. The medicine of the formula has the efficacies of liver smoothing and depression resolving, center supplementing and qi boosting, qi moving and stomach harmonizing, and dampness eliminating and spleen invigorating, has special curative effects on chronic gastritis (comprising superficial gastritis, erosive gastritis and atrophic gastritis), gastric ulcer and duodenal ulcer, and has the advantages of short treatment course, fast effectiveness, and reaching of the effective rate of 98%.
Owner:随洪涛

Pure Chinese medicine preparation for preventing and treating enteron disease and improving self phylactic power, and preparation method thereof

The invention relates to a Chinese traditional medicine and a preparation method thereof, in particular to a pure Chinese traditional medicine preventing preparation which can effectively treat outdated, superficial, and atrophic gastritis, ulcer, edema, and acute and chronic gastroenteritis, hepatocholangeitis, and malignancy, and can improve the immunity of the patients, and a preparation method thereof. The herbal preparation is composed of more than 100 pure Chinese traditional medicines according to the proportioning by weight: dzho milk made calcite, zuota, jade, coral, pearl, tabasheer, saffron, clove, nutmeg, cardamom, Fructus Tsaoko, bezoar, Phytolacca acinosa, yellow corydalis, iris, Panax pseudoginseng, coriander, rutabaga, double-blossom groundsel, red sal ammoniac, purple sal ammoniac, Sikkimese rock astragalus root, stenophyllous ground touching plum, Tibetan arris vegetable, Himalayas red Jessamine, caltrop, Nangjuguique, veronica, etc. The preparation method includes six procedures of crushing, mixing, making pill, polishing, and packaging. The Chinese traditional medicine of the invention has notable curative effect, simple medicament form, and simple production process, and is worthy to be popularized and applied.
Owner:西藏嘉黎县藏医院

Chinese medicine composite for treating chronic atrophic gastritis and preparation method thereof

The invention discloses a Chinese medicine composite for treating chronic atrophic gastritis and a preparation method thereof. The Chinese medicine composite mainly comprises the following active pharmaceutical ingredients: jobstears seed, rhizoma dioscoreae, pericarpium citri reticulatae, fructus aurantii immaturus, radix aristolochiae, ligusticum chuanxiong, Lignum aquilariae resinatum, rhizoma corydalis, stir-fried frankincense, stir-fried myrrh, pericarpium citri reticulatae viride, radix scrophulariae, rhizoma cyperi, styrax, radix trichosanthis, radix rehmanniae preparata, peach seed, safflower, medicated leaven, fructus setariae germinatus, dandelion, honeysuckle flower, rhizoma coptidis, radix et rhizoma rhei, radish seed, rhizoma curcumae longae, grassleaf sweetflag rhizome, cortex magnoliae officinalis and tuckahoe, and the like. The Chinese medicine composite can be prepared to be any common oral preparation according to the conventional Chinese medicine preparation method. The Chinese medicine composite can obviously improve abdominal distention that is manifest due to more food intake, tastelessness and insipidity, vague pain and complaint in the gastric cavity, lassitude, athrepsy, anorexia, anaemia and the like and the complications including gastric bleeding, gastrelcosis, anaemia and gastric cancer, and the like, which has definite clinical effect, obvious curative effect and fast desired effect.
Owner:TAIYI HEPU BEIJING RES INST OF TCM

Vascular four-dimensional reconstruction method in NOT gate-controlled ICUS (intravascular ultrasound) image sequence

The invention discloses a vascular four-dimensional reconstruction method in a NOT gate-controlled ICUS (intravascular ultrasound) image sequence. The method comprises the following steps: accurately positioning an ultrasonic catheter retracement path by utilizing a pair of approximate orthorhombic CAG (chronic atrophic gastritis) image sequences collected with an ICUS image synchronously; carrying out four-dimensional reconstruction on a morphological structure of a target vessel section containing possibly existing plaques through combining the cross section information of a vessel lomen extracted from the ICUS image; and reproducing true forms of coronary vessels at each time phase in a cardiac cycle. With the adoption of the vascular four-dimensional reconstruction method in the NOT gate-controlled ICUS image sequence, the four-dimensional reconstruction of the morphological structure of a coronary artery target vessel section containing the possibly existing plaques is realized, the true forms of the target vessel section at different time phases in the cardiac cycle can be comprehensively and truly reflected; and more reliable accordance can be provided for clinical diagnosis and treatment of coronary arteriesarteriosclerosis osteolytic lesions and research of biomechanical characteristics of coronary artery vascular tissues and the like. The method does not need an ECG-gating acquisition device, and also does not need ECG signals, so that the interventional examination time is greatly shortened, and the requirements on the original image data are reduced.
Owner:NORTH CHINA ELECTRIC POWER UNIV (BAODING)

Method for building spleen-deficiency chronic atrophic gastritis gastric precancerous lesions animal model

InactiveCN102648701ASyndrome of spleen deficiencyHave body temperatureIn-vivo testing preparationsAnimal husbandryNitrosoRat model
The invention relates to a method for building a spleen-deficiency chronic atrophic gastritis gastric precancerous lesions animal model. The method is based on the existing spleen-deficiency rat model and the existing chronic atrophic gastritis rat model and is used for building the animal model through united copy of free drinking of N-methyl-N '-nitro-N -nitrosoguanidine (MNNG) solution, irregular eating and purgation. The method comprises the following specific steps of: preparing 10mg / L MNNG storage solution by utilizing sterilized tap water, preparing 80 to 200 mug / mL MNNG solution in temporary use to substitute the drinking water to be drunk freely by the rats, and adopting the free drinking of MNNG as the beginning of the modeling; copying a spleen-deficiency syndrome through irregular eating and improved purgation way, feeding the rats on alternate days since the fifth week after the modeling, and utilizing qi-activating decoction for gavage in a dose of 1 to 3ml per rat every day in the seventh weak; and continuing the modeling for 12 weeks. The animal model built through the method is identical to or similar with the clinical syndrome and physical signs of middle-late lesions in chronic atrophic gastritis. After being verified in repeatedly modeling, the method has good repeatability and good stability. The built model is suitable for selecting traditional Chinese medicine for treating the chronic atrophic gastritis through a traditional Chinese medicine spleen treatment method.
Owner:潘华峰

Oral liquid for treating chronic atrophic gastritis

The invention belongs to the technical field of traditional Chinese medicines and relates to oral liquid for treating chronic atrophic gastritis. The oral liquid is prepared by the following components in parts by weight: 10 parts of Zhejiang white atractylodes rhizome, 15 parts of poria cocos, 10 parts of orange peel, 10 parts of pinellia tenata breit, 10 parts of vinegar rhizoma cyperi, 10 parts of fructus amomi, 10 parts of mangnolia officinalis, 10 parts of vinegar curcuma aromatic, 15 parts of artemisia anomala, 6 parts of cassia twig, 10 parts of rhizoma corydalis, 10 parts of hawthorn, 10 parts of roasted malt, 10 parts of roasted medicated leaven, 10 parts of lindera aggregate, 15 parts of radix paeoniae alba, 12 parts of radix pseudostellariae and 3 parts of liquorice. The oral liquid provided by the invention has the effects of relieving inflammatory cell infiltration, regulating cellular immunity and humoral immunity function, restraining the activity of pepsinogen to promote proliferation and recovery thereof, strengthening barrier protection function of the mucosa, regulating gastrointestinal motility, increasing permeability of gastric mucosa, improving blood circulation of the mucosa, promoting atrophic glands to recover, and delaying or reversing progression of diseases.
Owner:李郑生

Traditional Chinese medicine formulation for treating gastrosis and preparation method thereof

The invention relates to a Chinese patent medicine for treating gastric diseases. The Chinese patent medicine is characterized in that the medical prescription comprises prepared milkvetch root, cassia twig, medcinal evodia fruit, cassia bark, cuttlebone, peach seed, safflower, Chinese angelica, Szechuan lovage rhizome, red paeony root, salvia miltiorrhiza root, tree peony bark, rhizoma corydalis, wenyujin concise rhizome, common burreed rhizome, zedoary, leech, costustoot, bitter orange, combined spicebush root, golden thread, prepared liquoric root and rehmannia root. Compared with the prior Chinese patent medicines for treating the gastric diseases, the Chinese patent medicine of the invention has more reasonable formula, the synergy among various medicine components can promote the blood circulation of gastrointestinal mucosa, can rapidly recover the inflammation parts and the gastric ulcer surfaces thereof and can achieve the treatment effect on activating blood circulation, activating qi-flowing, relieving pain, nourishing qi, strengthening spleen and regulating spleen and stomach, the efficacy is remarkable and the Chinese patent medicine has no toxicity or side effects; the formula has the efficiency on swallowing acid, warming stomach, benefiting qi for warming stomach, dispelling cold, activating qi, activating blood circulation and relieving pain. The Chinese patent medicine is mainly used for gastric ulcer and duodenal ulcer caused by deficient cold of spleen and stomach, cold coagulation and blood stasis, as well as chronic atrophic gastritis.
Owner:陕西东泰制药有限公司

Traditional Chinese medicine preparation for treating chronic atrophic gastritis

The invention discloses a traditional Chinese medicine preparation for treating chronic atrophic gastritis. The traditional Chinese medicine preparation is prepared from the following ingredients in parts by weight: 10-20 parts of radix bupleuri, 10-20 parts of bighead atractylodes rhizome, 10-20 parts of astragalus membranaceus, 10-20 parts of fructus aurantii, 10-20 parts of corydalis tuber, 10-20 parts of sculellaria barbata, 8-18 parts of fructus amomi, 8-18 parts of agastache rugosus, 8-18 parts of fingered citron, 8-18 parts of radix paeoniae rubra, 8-18 parts of radix paeoniae alba, 8-18 parts of citron, 8-18 parts of armeniaca mume, 8-18 parts of concha arcae, 8-18 parts of fructus evodiae, 8-18 parts of radices trichosanthis, 8-18 parts of coxtex moutan, 8-18 parts of rhizoma bletillae, 8-18 parts of garden burnet, 8-18 parts of trogopterus dung, 20-40 parts of herba patriniae, 20-40 parts of oldenlandia diffusa, 2-12 parts of coptis chinensis, 2-12 parts of curcuma zedoary, 2-12 parts of scorpion and 2-12 parts of liquorice. The traditional Chinese medicine preparation is prepared by using traditional Chinese herbs as raw materials, selecting genuine medicinal materials and following the traditional processing method and has effects of soothing liver, regulating qi, strengthening spleen and stomach, removing heat from liver for nourishing the stomach, dissolving phlegm and dispersing blood stasis. Starting from regulating qi and blood of viscera, the traditional Chinese medicine preparation reflects the whole concept of traditional Chinese medicine and the drug use characteristic of treatment based on syndrome differentiation, thereby removing liver depression, spleen deficiency, stagnated heat and blood stasis, and achieving the purpose of curing chronic atrophic gastritis.
Owner:许建成

External application medicine for treating atrophic arthritis

The invention discloses a medicine for external application for treating rheumatoid arthritis and relates to medicine for treating rheumatoid arthritis. The preparation method of the medicine for external application comprises the following steps: (1) after ferrous powder, active carbon powder, salt, vermiculite, wormwood and lavender powder are ground into powder and are evenly mixed, the powder is subpackaged into bags which are sealed and are placed into a shady place for standby; (2) after futokadsura stem, orientavine, radix paeoniae lactiflorae, phellodendron, radix sileris and aconite are ground into powder and are evenly mixed, the powder is fixed on a colloid face and is prepared into a patch; and (3) an automatic heating layer and a medicine layer with various Chinese medicinal herbs are combined with the medicine layer with various Chinese medicinal herbs arranged in the inner side and the automatic heating layer arranged in the outer layer. The medicine for external application is a pure Chinese medicine preparation, has no toxic side effect, can be used for a long time, is light and practical, can be used easily, and is suitable for the old and the young. The efficacy of the medicine for external application is much better than that of similar medicine. The medicine saves time and labor, and has good effect for treating rheumatoid arthritis.
Owner:王业富

Traditional Chinese medicine preparation for treatment of chronic gastritis

The invention relates to the technical field of traditional Chinese medicines, and in particular relates to a traditional Chinese medicine preparation for the treatment of chronic gastritis and a preparation method thereof. The traditional Chinese medicine preparation is characterized by comprising the following raw materials by weight percentage: 5-15% of codonopsis, 4-12% of tangerine peel, 5-15% of yam, 1-5% of dried ginger, 5-15% of radix scrophulariae, 7-16% of dark plum, 5-15% of radix glehniae, 5-15% of polygonatum kingianum (steamed), 5-15% of white atractylodes rhizome (stir-baked), 5-16% of hawthorn (stir-baked), 5-15% of semen cuscutae (wrap-decocted), 4-12% of bamboo shavings, 5-15% of reed rhizome, 5-15% of dandelion, 5-15% of citrus aurantium, 4-12% of dendrobium, 5-15% of radix ophiopogonis, 4-12% of mint, 5-15% of white peony root, and 4-12% of licorice. The beneficial effects of the traditional Chinese medicine preparation are as follows: either in the dose form of capsules or granules, the traditional Chinese medicine preparation has an exact and significant curative effect for the treatment of chronic superficial gastritis and atrophic gastritis, and is widespread in clinical use, safe and non-toxic side effects; and an appropriate extension of the treatment course of the preparation helps to improve the curative effect on chronic gastritis, so the traditional Chinese medicine preparation is a major breakthrough in traditional Chinese medicines for treatment of chronic gastritis.
Owner:韩兴霞

Traditional Chinese medicine composition for treating chronic atrophic gastritis

The invention belongs to the field of traditional Chinese medicines for treating chronic atrophic gastritis. A traditional Chinese medicine composition disclosed by the invention mainly comprises the following raw materials in parts by weight: 8-15 parts of pilose Asiabell root, 8-15 parts of membranous milkvetch root, 8-15 parts of stir-fried largehead atractylodes rhizome, 8-15 parts of Indian buead, 10-20 parts of Chinese sage herb, 10-20 parts of glabrous greenbrier rhizome, 10-20 parts of raw coix seed, 10-20 parts of radix salviae miltiorrhizae, 8-15 parts of costustoot, 8-15 parts of caulis perllae, 8-15 parts of charred hawthorn fruit, 8-15 parts of medicated leaven and 5-10 parts of raw liquoric root. The traditional Chinese medicine syndrome comprehensive curative effects of clinical 40 cases of patients are as follows: clinical 20 cases are cured, 5 cases produce effects, 11 cases are effective, and the total effective rate is 90.0%. The endoscopic pathological comprehensive curative effects are as follows: clinical 16 cases are cured, 2 cases produce effects, 7 cases are effective, and the total effective rate is 62.5%. The traditional Chinese medicine composition disclosed by the invention has the effects of tonifying qi, activating spleen, eliminating dampness, dredging channels and the like, and has the advantages of short treatment course, significant curative effects and no toxic or side effects.
Owner:JIANGSU PROVINCE INST OF TRADITIONAL CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products